Objective Standards of care regarding obstetric management of life-threatening anomalies are not defined. It is hypothesised that physicians' management of these pregnancies is variable and influenced by demographic factors.
Design A questionnaire was mailed to members of the Society of Maternal–Fetal Medicine with valid US addresses assessing obstetric management of both ‘uniformly lethal’ (eg, anencephaly, renal agenesis) and ‘uniformly severe, commonly lethal’ (eg, trisomy 13 and 18) anomalies. Respondents were asked to answer as if not limited by state/institutional restrictions. Fisher's exact or χ2 tests were used as appropriate and correction made for multiple comparisons in analyses that were not prespecified.
Results The response rate was 36% (732/2038). Nearly 100% of respondents discuss termination for both uniformly and commonly lethal anomalies. In continuing pregnancies, with patient request for obstetric non-intervention 99% of providers would comply for either uniformly or commonly lethal anomalies. The majority ‘encourage’ such management, but some were non-directive or discouraged this management. In continuing pregnancies, with patient request for full obstetric intervention the majority of respondents was willing to comply for both uniformly (71%) and commonly (82%) lethal anomalies. While most practitioners ‘discouraged’ full intervention, some were non-directive or encouraged this management. Demographics and severity of anomaly influenced counselling.
Conclusion Discrepancies exist regarding the management of life-threatening fetal anomalies. Patients may be offered different options based on practitioner demographics. The majority of physicians comply with patient wishes. Differences were noted when comparing the management of lethal with that of severe commonly lethal anomalies, suggesting that practitioners make a distinction when counselling patients.
- genetic counselling/prenatal diagnosis
- obstetrics and gynaecology
- prenatal diagnosis
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests None.
Ethics approval Ethics approval was obtained from the University of Utah institutional review board.
Provenance and peer review Not commissioned; externally peer reviewed.
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Responsibly counselling women about the clinical management of pregnancies complicated by severe fetal anomalies
- Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data
- Socioeconomic inequalities in pregnancy outcome associated with Down syndrome: a population-based study
- New findings for phenotype–genotype correlations in a large European series of holoprosencephaly cases
- Mutations in ZIC2 in human holoprosencephaly: description of a Novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals
- Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists
- Clinicians’ perspectives of parental decision-making following diagnosis of a severe congenital anomaly: a qualitative study
- Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function
- Cyclopia: isolated and with agnathia–otocephaly complex
- Ultrasound structural fetal anomaly screening: an update